Talking it out: could CBT ease anxiety and depression in IBD patients?

NCT ID NCT05377840

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether cognitive behavioral therapy (CBT) can reduce anxiety and depression in people with inflammatory bowel disease (Crohn's disease or ulcerative colitis). Participants receive either psychologist-led or self-administered CBT over 8 weeks. The goal is to see if mental health improves, offering a potential non-drug option for managing these common emotional challenges.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Cognitive Behavioral Therapy (CBT)

What this could lead to

If it works, this could point toward a drug-free way to improve mental health in people with IBD.

What could go wrong

This is a very small, early study with only 13 participants, so results may not apply to everyone. CBT requires time and effort, and not everyone responds.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder Crohn disease Depression ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Yale New Haven Hospital

    New Haven, Connecticut, 06520, United States